TrialBritish journal of haematology2020

First-line R-CVP versus R-CHOP induction immunochemotherapy for indolent lymphoma with rituximab maintenance. A multicentre, phase III randomized study by the Polish Lymphoma Research Group PLRG4.

Jan Walewski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.